TARAProtara Therapeutics, Inc.

$216M

Q4 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$7M

Net Income

-$7M

EPS (Diluted)

$-16.98

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$844,000

Balance Sheet

Total Assets

$44M

Total Liabilities

$5M

Stockholders' Equity

$38M

Cash & Equivalents

$36M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$7M	-$6M	-11.0%
Net Income	-$7M	-$6M	-9.8%

TARA Q4 2016 Earnings — Protara Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena